Prevail Therapeutics Inc. (PRVL) NASDAQ/NMS (GLOBAL MARKET)

$23 - (-)

Market Cap: -

As of 01/21/21 12:00 AM EST. Market closed.

(PRVL)

Prevail Therapeutics Inc. (PRVL)
NASDAQ/NMS (GLOBAL MARKET)

$23
- (-)

Market Cap: -

As of 01/21/21 12:00 AM EST. Market closed.

Add to Portfolio
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
PRICE CHART FOR PREVAIL THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$22.97
Previous Close
$23
Days Range
$22.97 - $23.13
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
34,246,433
Open
$22.97
Previous Close
$23
Days Range
$22.97 - $23.13
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
34,246,433
FINANCIAL STATEMENTS FOR PREVAIL THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR PREVAIL THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Tyto Acquisition Corp10% OwnerJan 22, 2021 Buy$22.5034,284,789771,407,753100Jan 22, 2021, 04:26 PM
Abeliovich AsaPresident & CEODec 30, 2020 Option Exercise$23.0289,0372,049,6322,385,756Dec 31, 2020, 04:54 PM
Abeliovich AsaPresident & CEODec 30, 2020 Option Exercise$9.84125,7931,237,6562,474,793Dec 31, 2020, 04:54 PM
Minkow EmilyChief Business OfficerDec 24, 2019 Option Exercise$0.1813,0002,34013,000Mar 11, 2020, 04:47 PM
Thompson Peter A.DirectorJun 24, 2019 Buy$17.00882,35214,999,98413,822,463Jun 26, 2019, 04:56 PM
GORDON CARL LDirectorJun 24, 2019 Buy$17.00882,35214,999,98413,822,463Jun 26, 2019, 04:55 PM
ORBIMED ADVISORS LLCDirectorJun 24, 2019 Buy$17.00882,35214,999,98413,822,463Jun 26, 2019, 04:54 PM
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Tyto Acquisition Corp10% Owner01/22/2021771,407,753
Abeliovich AsaPresident & CEO12/30/20202,049,632
Abeliovich AsaPresident & CEO12/30/20201,237,656
Minkow EmilyChief Business Officer12/24/20192,340
Thompson Peter A.Director06/24/201914,999,984
GORDON CARL LDirector06/24/201914,999,984
ORBIMED ADVISORS LLCDirector06/24/201914,999,984
BUYBACK ANNOUNCEMENT(S) FOR PREVAIL THERAPEUTICS INC
LOADING...